Results 191 to 200 of about 58,375 (292)

FRI-13 Molecular imaging (Gallium-68 SMS-receptor PET/CT) and peptide receptor radionuclide therapy (PRRNT) of GEP-neuroendocrine neoplasms (GEP-NEP)

, 2013
Richard P. Baum
openalex   +1 more source

From fixed activities to personalized treatments in radionuclide therapy: lost in translation? [PDF]

, 2017
Glenn Flux, Katarina Sjögreen Gleisner, Claudio Chiesa, Michael Laßmann, Nicolas Chouin, Jonathan Gear, Manuel Bardiès, Stéphane Walrand, Klaus Bacher, Uta Eberlein, Michael Ljungberg, Lidia Strigari, Eric P. Visser, Mark Konijnenberg   +13 more
openalex   +1 more source

²¹²Pb in targeted radionuclide therapy: a review. [PDF]

EJNMMI Radiopharm Chem
Scaffidi-Muta JM, Abell AD.
europepmc   +1 more source

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient’s therapy course

, 2021
Daphne M. V. de Vries–Huizing, Michelle W. J. Versleijen, Michiel Sinaasappel, Iris Walraven, Martine M. Geluk–Jonker, Margot Tesselaar, Jeroen J. M. A. Hendrikx, Berlinda J. de Wit–van der Veen, Marcel P. M. Stokkel   +8 more
openalex   +1 more source

Personalized prediction model for scar response after radionuclide therapy: development and validation in a Chinese cohort. [PDF]

Front Med (Lausanne)
Su J, Chen J, Wang T, Song T, Xu H, Lin S, Lin T.   +6 more
europepmc   +1 more source

The potential of targeted radionuclide therapy to treat hypoxic tumor cells

Sylvia T.M. Wenker, Sanne A. M. van Lith, G Tamborino, M.W. Konijnenberg, Johan Bussink, S. Heskamp   +5 more
openalex   +1 more source

Combined hormonal and radionuclide-medication therapy of prostate cancer

, 2018
V. Grygorenko, O.V. Scherbina, С. С. Волков, Rostyslav Danylets, М. В. Вікарчук   +4 more
openalex   +2 more sources

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours [PDF]

, 2013
Lisa Bodei, Jan Mueller‐Brand, Richard P. Baum, Marianne E. Pavel, Dieter Hörsch, M. Sue O’Dorisio, Thomas M. O’Dorisio, James R. Howe, Marta Cremonesi, D. J. Kwekkeboom, John J. Zaknun   +10 more
openalex   +1 more source

Preclinical Lutetium-177 Intracellular Dosimetry of Target Cancers in Radionuclide Therapy. [PDF]

J Med Phys
Lunev AS, Petrosova KA, Ternovskaya KE, Zakharkina AE, Nigmatulina AI.   +4 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective.

, 2018
Agnieszka Kolasińska-Ćwikła, Anna Łowczak, Katarzyna Maciejkiewicz Maciejkiewicz, Jarosław B. Ćwikła   +3 more
openalex   +2 more sources